[Comparative characteristics of a test system for detecting antibodies to hepatitis C virus]. 1996

E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev

The sensitivities and specificities of enzyme immunoassay (EIA) kits for the detection of antibodies to hepatitis C virus (HCV) were compared in donor blood screening. A total of 3308 donors were examined using Akvapast immunodiagnosticum (St. Petersburg), lot 12. Anti-HCV antibodies were detected in 43 (1.3%) subjects. Blood sera of these donors were additionally investigated using other lots of Akvapast, Hepascan (Bioservice, Moscow), Blot-0.5 (Bioservice, Moscow), and immunoComb (France). The studies demonstrated that none of the agents used can be acknowledged as ideally sensitive and specific for the detection of anti-HCV antibodies. Maximally sensitive diagnostic kits should be preferred for the screening of donors of blood components and for other mass surveys. Highly-specific test systems are advisable for profound examinations and diagnostic monitoring. The creation of a system of reference and expert diagnosis of hepatitis C remains a pressing task.

UI MeSH Term Description Entries
D008297 Male Males
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
January 2004, Voprosy virusologii,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
January 1991, Voprosy virusologii,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
October 1958, The Cornell veterinarian,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
January 1998, Voprosy virusologii,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
January 1989, Voprosy virusologii,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
May 1981, Tropical animal health and production,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
May 1968, American journal of clinical pathology,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
May 1993, Gastroenterologia Japonica,
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
August 1989, Lancet (London, England),
E B Zhiburt, and N V Bel'gesov, and V V Danil'chenko, and N B Serebrianaia, and V K Potepun, and S V Sidorkevich, and V B Vasiliuk, and K Iu Zhuravlev
May 2002, Journal of clinical microbiology,
Copied contents to your clipboard!